Innovus Pharmaceuticals, Inc. INNV Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Innovus Pharmaceuticals, Inc. INNV Company Overview 

Stock Message Board http://investorshangout.com/search?q=INNV&...mp;yt1=Go!

Innovus Pharmaceuticals, Inc. INNV Current Price and Quotes
0.33
Previous Close
0.30
Open
0.33

Daily Range
0.33 - 0.33
52wk Range
1.75 - 0.15

Volume
19,200
Dividend
N/A

Average Vol (3m)
10,857
Yield
N/A

Innovus Pharmaceuticals, Inc. INNV
Company Information
4275 Executive Square
Suite 200
San Diego, CA 92037

Website: http://www.innovuspharma.com
Phone: 858-964-5123
Email: info@innovuspharma.com
Find us on:      

Innovus Pharmaceuticals, Inc. INNV
Headquartered in La Jolla, California, Innovus Pharma (INNV) is an emerging pharmaceutical company that develops, in-licenses, acquires and markets proprietary pharmaceutical products in sexual dysfunction, dermatology, autoimmune and respiratory diseases.

The company's management team has a proven track record in product acquisition, development, commercial partnership and commercialization.

Innovus Pharmaceuticals, Inc. INNV
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001411879
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. Not Available
Employees 4 a/o Jun 01, 2013
Company Officers/Contacts
Bassam Damaj, Ph D President, CEO
Morgan Brown EVP, CFO
Company Directors
Henry Esber Chairman
Bassam Damaj, Ph D
Vivian Liu
Ziad Mirza
Company Notes
Formerly=North Horizon, Inc. until 12-2011
Service Providers
Auditor/Accountant
EisnerAmper LLP
750 Third Avenue
New York, NY, 10017
United States

Legal Counsel
Sheppard, Mullin, Richter & Hampton LLP
333 South Hope Street
Los Angeles, CA, 90071
United States

Investor Relations Firm
Chesapeake Group

Innovus Pharmaceuticals, Inc. INNV
INNV Security Details
Share Structure
Market Value1 $5,852,362 a/o Aug 30, 2013
Shares Outstanding 17,734,430 a/o Aug 08, 2013
Float 3,271,616 a/o Jul 31, 2013
Authorized Shares 150,000,000 a/o Apr 17, 2012
Par Value  0.001
Shareholders
Shareholders of Record 503 a/o Mar 19, 2013
Security Notes
Capital Change=shs decreased by 1 for 10 split. Pay date=12/06/2011.
Short Selling Data
Short Interest 0 (-100%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Interwest Transfer Co., Inc.

Innovus Pharmaceuticals, Inc. INNV Recent News


Aug 19, 2013 Innovus Pharma Provides Corporate Update
Jul 29, 2013 Innovus Signs Co-Promotion Agreement With Consortia Health for EjectDelay(TM) For Premature Ejaculation
Jul 3, 2013 Innovus Pharma Initiates Primate Safety Studies of Its Products That Affect Premature Ejaculation and Penile Sensation
Jun 27, 2013 Innovus Appoints Robert E. Hoffman to Newly Formed Business and Finance Advisory Board


Innovus Pharmaceuticals, Inc. INNV Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 2 59 - -
Sales, General and Admin. 217 2,130 54 9
Non-Recurring Items - - - -
Other - - - -
Operating Income (219) (2,189) (54) (9)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (219) (2,189) (54) (9)
Interest Expense 17 68 16 -
Earnings Before Tax (237) (2,256) (70) (9)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (237) (2,256) (70) (9)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (237) (2,256) (70) (9)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (237) (2,256) (70) (9)

INNV Innovus Pharmaceuticals, Inc. Research DD Guide

INNV Innovus Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=INNV&...mp;yt0=Go!
INNV Innovus Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/INNV/quote
INNV Innovus Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/INNV/chart
INNV Innovus Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/INNV/company-info
INNV Innovus Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/INNV/news
INNV Innovus Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/INNV/financials
INNV Innovus Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/INNV/filings
INNV Innovus Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/INNV/short-sales
INNV Innovus Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/INNV/insider-transactions
INNV Innovus Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/INNV/research
INNV Innovus Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=INNV
INNV Innovus Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=INNV+Historical+Prices
INNV Innovus Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=INNV
INNV Innovus Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=INNV+Basic+Chart
INNV Innovus Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=INNV+Basic+Tech.+Analysis
INNV Innovus Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=INNV+Headlines
INNV Innovus Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=INNV+Press+Releases
INNV Innovus Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=INNV+Profile
INNV Innovus Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=INNV+Key+Statistics
INNV Innovus Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=INNV+Industry
INNV Innovus Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=INNV+Major+Holders
INNV Innovus Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=INNV+Insider+Transactions
INNV Innovus Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=INNV+Insider+Roster
INNV Innovus Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=INNV
INNV Innovus Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=INNV
INNV Innovus Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=INNV+Cash+Flow&annual
INNV Innovus Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/INNV
INNV Innovus Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/INNV
INNV Innovus Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/INNV:US
INNV Innovus Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=INNV
INNV Innovus Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=INNV
INNV Innovus Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/INNV
INNV Innovus Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=INNV
INNV Innovus Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/INNV/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 25

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 21

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 22

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 28

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 23

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 26

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 22

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 25

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 10

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 18

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading

Top 5 Most Recently Viewed Articles

Snap Inc. Faces Investor Scrutiny Over Ad Platform Mishaps

Updated Category News Views 335

Snap Inc. Under Fire for Alleged Misleading Statements In today's dynamic digital advertising landscape, Snap Inc. (SNAP) finds itself in a challenging situation. Recently, a class action lawsuit has been initiated against the company, alleging that it misrepresented the performance of its advertising platform and its potential for growth. Understanding the Allegations...

Continue Reading
Intelligent Bio Solutions Partners with Major Industrial Provider

Updated Category News Views 135

Groundbreaking Partnership for Intelligent Bio Solutions Intelligent Bio Solutions Inc. (NASDAQ: INBS) is making strides in the medical technology industry with a remarkable new partnership that enhances its reputation. Recently, this innovative company secured a substantial contract with one of the leading industrial service providers in the United Kingdom, marking a...

Continue Reading
Strategies Behind Synopsys Inc.'s Stock Movement and Trends

Updated Category News Views 150

Understanding Recent Stock Movements of Synopsys Inc. In recent trading, Synopsys Inc. (NASDAQ: SNPS) saw a notable increase of 4.9%, highlighting significant interest from investors. The company experienced a substantial uptick after a pivotal trading signal emerged. The Power Inflow Signal Synopsys's stock performance often reflects underlying trends influenced by...

Continue Reading
Seres Therapeutics Reveals Key Financial Insights for Q3 2025

Updated Category News Views 169

Seres Therapeutics to Discuss Third Quarter Financial Results Seres Therapeutics, Inc. (NASDAQ: MCRB), a pioneering company in the realm of live biotherapeutics, is set to host an important conference call regarding its third quarter financial results. On a date soon approaching, the company's management will provide insights into its fiscal performance and highlight...

Continue Reading
Quaker Houghton Declares Significant Quarterly Cash Dividend

Updated Category News Views 116

Quaker Houghton Declares Significant Quarterly Cash Dividend The Board of Directors of Quaker Houghton (NYSE: KWR) has announced a quarterly cash dividend of $0.485 per share. This decision reflects the company's robust financial health and commitment to maximizing shareholder value. The dividend is set to be paid to shareholders of record at the close of business on...

Continue Reading